America Stem Cell, Inc. (Helotes, TX) Initiates a Phase I/II Trial of ASC-101 in Patients With Hematologic Malignancies Undergoing Dual-Cord Transplantation

SAN ANTONIO--(BUSINESS WIRE)--America Stem Cell, Inc. announced today the initiation of a single-center study at The University of Texas MD Anderson Cancer Center evaluating ASC-101 in dual-umbilical cord transplantation in patients with hematologic malignancies.